SVETLANA MUSHEYEVA: Open Payments
NPI 1659795011 · LYNBROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,036 in 98 payments from 23 companies in 2025. Trend: 2023 $808 · 2024 $1,540 · 2025 $2,036
Food & beverage: $2,036
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $446 |
| Neurocrine BioSciences, Inc. | 7 | $239 |
| Otsuka America Pharmaceutical, Inc. | 7 | $137 |
| BIOTRONIK INC. | 2 | $131 |
| Grifols USA, LLC | 5 | $126 |
| Lundbeck LLC | 5 | $117 |
| UCB, Inc. | 5 | $117 |
| Alexion Pharmaceuticals, Inc. | 6 | $115 |
| Amgen Inc. | 4 | $85 |
| Axsome Therapeutics, Inc. | 2 | $57 |
Products named: INGREZZA, UBRELVY, QULIPTA, REXULTI, Gamunex-C, ULTOMIRIS, VYEPTI, UPLIZNA.
Industry payments across NY — which companies pay providers there.
